Scientists pinpoint ideal opioid dose for smoother airway insertion
NCT ID NCT06289829
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study aims to find the best dose of remifentanil, a fast-acting opioid, for inserting a laryngeal mask airway (a type of breathing tube) during anesthesia with remimazolam. Researchers will test different doses in 60 adults having short elective surgeries, adjusting the dose based on whether insertion is successful. The goal is to improve patient comfort and safety by reducing movement or breathing problems during the procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remifentanil
- What this could lead to
- If successful, this could help anesthesiologists use the right dose of remifentanil for smoother and safer airway device insertion.
- What could go wrong
- This is a small, early-phase study with only 60 patients, so results may not apply to everyone. The optimal dose found may still cause side effects or fail in some cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT, LARYNGEAL MASKS, REMIMAZOLAM, REMIFENTANIL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Severance Hospital
Seoul, South Korea